DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
octreotide
Octreotide
Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.
octreotide - List of case studies
- spreading pancreatic cancer
-
of her disease progression, I recommend treating with Octreotide LAR (sandostatin) monthly and increasing the dose as ... the patient’s disease progresses while on Octreotide LAR, a chemotherapy combination of platinum and etoposide would ... patient may have a very favorable response to Octreotide and her disease may be manageable for quite some time. ...
- Small Cell Neuroendocrine Tumor of the Cervix – additional opinion
-
NECs (WD-NECs; n=11) received therapy with octreotide long-acting release and interferon-alpha-2b for a maximum of 1 ... platinum, paclitaxel, carboplatin, etoposide, octreotide, interferon-alpha-2b, combination cisplatin, L-leucovorin, ... platinum, paclitaxel, carboplatin, etoposide, octreotide, interferon-alpha-2b, combination cisplatin, L-leucovorin, ...
- Neuroendocrine Neoplasia
-
was performed with medications similar to Somatostatin (octreotide 0.2 mg S.C.) which were well tolerated by the patient. ...
- Drugs
-
OAT (Oral anticoagulant therapy) OKI packet Octreotide Ocuvite Lutein Ocuvite Preservision Oliclinomel N-4 ...